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Abstract
Background: Intracystic carcinoma of the breast is a type of breast cancer with favorable prognosis where cancer
arises from the cystic wall. However, it is a relatively rare disease, and no general consensus has been reached on
its definition, including pathogenesis, extramural invasion, and lymph node metastasis.
Methods: Six patients who underwent surgery at the Department of Surgery at Asahikawa Medical University are
presented. In each patient, background factors, diagnosis, surgery, pathological diagnosis, and prognosis were
investigated.
Results: Fine needle aspiration showed class V disease in three patients and class III disease in the other three, and
lumpectomy was performed for class III patients. Three patients underwent breast-conserving surgery While
extramural invasion was seen in three patients, lymph node metastasis was absent in all patients.
Conclusion: When it is difficult to diagnose intracystic carcinoma of the breast by fine needle aspiration, active
lumpectomy is necessary. Because extramural invasion and lymph node metastasis have been reported, it is
necessary to carefully determine the range of excision and rationally perform lymph node dissection, such as
sentinel node biopsy.
Background
Intracystic carcinoma of the breast is a type of breast
cancer with favorable prognosis where cancer arises
from the cystic wall. It is a relatively rare disease, and
includes ductal carcinoma in situ according to the Japa-
nese Society for Breast Cancer.
However intracystic carcinoma is difficult to diagnose
than common breast carcinoma, no general consensus
has been reached on its definition, including pathogen-
esis, extramural invasion, and lymph node metastasis.
Six patients with this condition were clinically investi-
gated and a literature review was conducted.
Methods
Of 1160 breast cancer patients who underwent surgery
at Asahikawa Medical University Hospital from January
2001 to March 2010 subjects were six patients who
were histopathologically diagnosed with intracystic
carcinoma of the breast (0.5%). In each patient, back-
ground factors, diagnosis, surgery, pathological diagno-
sis, and prognosis were investigated.
Results
1. Background factors and preoperative diagnosis (Table 1)
Patients were one man and five women with an average
age of 73.3 years (range: 53 - 89 years); the average age
of patients with other forms of breast cancer in compar-
able stages was lower at 53.6 years (range: 28 - 86
years). The main complaint for all patients was a breast
lump, and none reported bloody discharge from the nip-
ple. The length of time from first symptoms to diagnosis
was relatively short at 1 - 3 months for the five women,
but longer at 1 year for the man. The male patient was
not aware of the existence of breast cancer in men, and
he visited the hospital only after the tumor had
increased in size.
One patient had undergone surgery for breast cancer
in the contralateral breast 18 years previously. Mammo-
graphy (MMG) showed a shape of mass, and ultrasono-
graphy (US) confirmed solid component with intracystic
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were variable, regular or irregular in shape. Fine needle
aspiration cytology (FNA) revealed light brown cystic
fluid in one patient and bloody fluid in the remaining
five. It was diagnosed by the Papanicolous classification.
Cytologic class was class V in three patients and class
III in the other three. Lumpectomy was performed on
the three patients with class III cytology.
2. Operation and pathology (Table 2)
Three patients underwent breast-conserving surgery and
the other three underwent mastectomy. With regard to
lymph nodes, axillary lymph node dissection was per-
formed on two patients and sentinel lymph node biopsy
on three patients; lymph node dissection was not per-
formed on one patient. Histopathological analyses
showed intracystic papillary carcinoma in all patients,
and lymph node metastasis was not seen. Postoperative
staging was either 0 or I. A concurrent malignant extra-
mural invasion was seen in four patients (DCIS in one
patient, and invasive ductal breast cancer in the other
three). One patient had multiple small invasive cancer-
ous lesions around the tumor. One patient tested nega-
tive for estrogen receptors and the remaining five tested
positive, and hormone therapy was performed for those
who tested positive (Tamoxifen (TAM) for the male
patient and aromatase inhibitor (AI) for the postmeno-
pausal women). In the three patients who underwent
breast-conserving surgery, radiotherapy was performed
on the remaining breast. At present, no recurrences
have been detected and all patients remain alive without
cancer.
Discussion
Intracystic carcinoma of the breast was first reported by
Brodie and colleagues [1], and it is a relatively rare dis-
ease, accounting for only 0.5 to 1.9% of all breast can-
cers [2,3]. According to the general rules for clinical and
pathological recording of breast cancer, a lesion loca-
lized in a cyst is defined as noninvasive intracystic
Table 1 Background factors and preoperative diagnosis
Age Sex Chief complain Duration of symptom Localization Size of tumor Liquid status Cytology
16 5 ♂ Breast mass 1 Y E 2.5 cm brown 3a
25 3 ♀ Breast mass 1 M A 2.5 cm bloody 3a
38 1 ♀ Breast mass 1 M C 3.0 cm bloody 5
48 0 ♀ Breast mass 3 M E 6.0 cm bloody 3b
58 9 ♀ Breast mass 2 M BE 3.5 cm bloody 5
67 4 ♀ Breast mass 1 M ED 2.5 cm bloody 3
Localization: A; The inner upper part, B; The inner lower part, C; The outside upper part, D; The outside lower part, E; The under areola part
Cytology was diagnosed by the Papanicolous classification.
Table 2 Operation method, pathological findings, receptor status, treatment and outcome
No Operative method P-stage Grade Extramural invasion Vascular invasion Receptor status Medical treatment
1 Bt+Ax 0 I - ly(-) v(-) ER(1+)
PgR(2+)
HER2(3+)
Endocrine therapy
(TAM)
2 Bp+Ax I I +(IDC) ly(-) v(-) ER(-)
PgR(-)
HER2(-)
-
3 Bp 0 I - ly(-) v(-) ER(3+)
PgR(3+)
HER2(2+)
Endocrine therapy
(AI)
4 Bt+SN I II +(IDC) ly(-) v(-) ER(3+)
PgR(-)
HER2(-)
Endocrine therapy
(AI)
5 Bt+SN I I +(DCIS) ly(-) v(-) ER(3+)
PgR(3+)
HER2(1+)
Endocrine therapy
(AI)
6 Bp+SN I I +(IDC) ly(-) v(+) ER(3+)
PgR(3+)
HER2(-)
Endocrine therapy
(AI)
Bt: Breast total resection, Bp: Breast partial resection, Ax: Axillal lymph node resection, SN: sentinel node biopsy, IDC: Invasive Ductal Carcinoma, DCIS: Ductal
carcinoma in situ, ly: lynph duct invasion, v: vessel invasion, ER: Esterogen reseptor, PgR: Progesteron reseptor, HER2: Human epidermal growth factor receptor
type2, TAM: Tamoxifen, AI: Aromatase inhibitor.
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extramural invasion [4]. However, because it is not easy
to prove whether a tumor develops in a benign cyst or a
cyst is formed due to the secondary changes associated
with tumor necrosis, there is no general consensus on
definition of this lesion, including pathogenesis, inva-
sion, and lymph node metastasis. The present report is
significant because breast cancer in which a lesion
existed within the cystic wall was investigated as intra-
cystic carcinoma of the breast.
Patients with intracystic carcinoma of the breast tend
to be older than patients with other forms of breast can-
cer. In our study, the average age was 73.4 years, which
is about 20 years older than the average age of other
breast cancer patients (53.6 years). The present study
also included one male patient. Since breast cancer in
men accounts for only about 1% of all breast cancers,
the incidence of intracystic carcinoma of the breast in
men appears to be higherand and there is equal to or
more than 5% of report [5,6].
Most patients with intracystic carcinoma of the breast
have symptoms such as a palpable mass and bloody dis-
charge, and it is relatively easy to delineate a timorous
lesion in the cyst by US. Moreover, cyst fluid is character-
istically bloody. FNA reveals class IV/V cytology in 63 -
65%, but malignant cells are not seen in some cases [7].
We perform FNA on tumorous lesions under US gui-
dance, and if intracystic carcinoma is suspected, cystic
fluid is bloody, or FNA reveals a cytologic grade of class
III or higher, we actively perform lumpectomy to con-
firm diagnosis. The level of CEA in the cystic fluid has
also been measured, with levels ≥ 400 ng/ml reported to
indicate malignancy [8]. Because many examples not to
be taking MRI imaging in our cases, it wasn’t possible
to have entered reviewing. There is a report which is
useful for the diagnosis of Intracystic carcinoma [9], and
it wants to review it in the future.
With regard to therapy, breast-conserving surgery
appears to be indicated, but there have been some
reports of extramural invasion, intraductal progression,
and axillary lymph node metastasis including microme-
tastases [10,11]. It is therefore necessary to consider the
indications for breast-conserving surgery, as in other
breast cancers. In the present study, extramural invasion
was seen in four of the six patients. Patients with extra-
mural invasion are at increased risk for lymph node
metastasis, and axillary lymph node dissection was
therefore performed in the past in this situation. How-
ever, in recent years, sentinel lymph node biopsy has
become a standard procedure, and in intracystic carci-
noma of the breast, sentinel lymph node biopsy should
be considered for preoperative class V diagnosis. When
lumpectomy is performed, sentinel lymph node biopsy is
difficult, and in such a case, a reductive operation such
as lymph node sampling is needed. With regard to post-
operative adjunctive therapy, the same standards as for
other types of breast cancer are employed.
Clinicopathological analyses were performed on six
patients with intracystic carcinoma of the breast. The
results suggested that lumpectomy should be actively
performed when cystic fluid is bloody and FNA reveals
class III cytology. Since there have been reports of extra-
mural invasion and lymph node metastasis, it will be
necessary to carefully determine the extent of resection
based on rapid pathological analysis and to perform
rational lymph node diagnosis, such as sentinel lymph
node biopsy.
Conclusion
When it is difficult to diagnose intracystic carcinoma of
the breast by fine needle aspiration, active lumpectomy
is necessary. Because extramural invasion and lymph
node metastasis have been reported, it is necessary to
carefully determine the range of excision and rationally
perform lymph node dissection, such as sentinel node
biopsy.
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